Back to search
FDAFDA · Food and drugs·Recall number D-1292-2022

Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV

Published August 3, 2022 · Recall initiated: July 5, 2022

Summary

FDA records drug Class I recall D-1292-2022, published August 3, 2022 and initiated July 5, 2022. Recalling firm: Mylan Pharmaceuticals Inc; Status: Terminated; Reported quantity: 253,200 pens (50,650/5 per packs); Lot: Lot #: BF21002895, Exp. Date Aug 2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Missing label: Label missing from some prefilled pens.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc
Distributor
Product was distributed nationwide within the United States
Lot
Lot #: BF21002895, Exp. Date Aug 2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV recalled?

Yes. FDA published recall D-1292-2022 on August 3, 2022. Reported hazard: Labeling: Missing label: Label missing from some prefilled pens.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release